EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform law.

Contacted: SENATE; Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO); Executive Office of the President (EOP); Government Accountability Office (GAO); Food & Drug Administration (FDA); White House Office; Internal Revenue Service (IRS); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL)

Defense DEF

Pharmacy issues related to the annual defense reauthorization (HR 1735,S 1376).

Contacted: Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Health Resources & Services Administration (HRSA); White House Office; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Congressional Budget Office (CBO); Federal Trade Commission (FTC); Government Accountability Office (GAO); Internal Revenue Service (IRS); Executive Office of the President (EOP); Office of Personnel Management (OPM)

Bills named: H.R. 1735 (114th)

Health Issues HCR

Regulatory policies related to the health reform law: structure, drug benefits, disclosure. Regulatory implementation of HITECH/accounting of disclosures. Issues regarding making prescription drugs more affordable. Restrictions on specialty tiering.

Contacted: Executive Office of the President (EOP); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Federal Trade Commission (FTC); SENATE; Office of Personnel Management (OPM); White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Internal Revenue Service (IRS); Labor, Dept of (DOL); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA)

Postal POS

Postal reform proposals, including rate reform, and their impact on 6 day mail delivery.

Contacted: Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); White House Office; SENATE; Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Food & Drug Administration (FDA); Internal Revenue Service (IRS); Medicare Payment Advisory Commission (MedPAC); Office of Personnel Management (OPM); Executive Office of the President (EOP); Federal Trade Commission (FTC)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General Legislative and regulatory issues such as direct negotiation. Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors prompt pay discounts from the definition of average sales prices. Medicare audit and preferred network restrictions. HR 244; HR 793.

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Internal Revenue Service (IRS); SENATE; Food & Drug Administration (FDA); Labor, Dept of (DOL); White House Office; Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Office of Personnel Management (OPM); Congressional Budget Office (CBO); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 244 (114th), H.R. 793 (114th)

Labor Issues/Antitrust/Workplace LBR

Legislation to exempt certain pharmacies from the antitrust laws for the purposes of negotiating with payers.

Contacted: SENATE; Food & Drug Administration (FDA); White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Government Accountability Office (GAO); Federal Trade Commission (FTC); Internal Revenue Service (IRS); Congressional Budget Office (CBO); Office of Personnel Management (OPM); Executive Office of the President (EOP)

Pharmacy PHA

Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR, specialty pharmacy tiering restrictions. Regulatory implementation of a pathway for the approval of biosimilars. REMs. 340b program reform. policies placing restrictions on pharmacy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse, including Medicare lock-in programs. General issues dealing with regulating pharmacy drug compounding. HR 1600.

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA); Internal Revenue Service (IRS); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); White House Office; Government Accountability Office (GAO); Labor, Dept of (DOL); Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC); Medicare Payment Advisory Commission (MedPAC); SENATE; Congressional Budget Office (CBO)

Bills named: H.R. 1600 (114th)